Sanara Medtech Earnings Estimate

SMTI Stock  USD 36.36  0.17  0.47%   
By analyzing Sanara Medtech's earnings estimates, investors can diagnose different trends across Sanara Medtech's analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for Sanara Medtech is based on EPS before non-recurring items and includes expenses related to employee stock options.
 
Yuan Drop
 
Covid
Sanara Medtech is projected to generate 0.0 in earnings per share on the 31st of December 2024. Sanara Medtech earnings estimates show analyst consensus about projected Sanara Medtech EPS (Earning Per Share). It derives the highest and the lowest estimates based on Sanara Medtech's historical volatility. Many public companies, such as Sanara Medtech, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm. By analyzing Sanara Medtech's earnings estimates, investors can diagnose different trends across Sanara Medtech's analyst sentiment over time as well as compare current estimates against different timeframes. As of now, Sanara Medtech's Gross Profit is increasing as compared to previous years. The Sanara Medtech's current Gross Profit Margin is estimated to increase to 0.92, while Pretax Profit Margin is projected to decrease to (0.07).
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sanara Medtech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
For more detail on how to invest in Sanara Stock please use our How to Invest in Sanara Medtech guide.

Sanara Medtech Earnings per Share Projection vs Actual

About Sanara Medtech Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Sanara Medtech earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Sanara Medtech estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Sanara Medtech fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.
Last ReportedProjected for Next Year
Retained Earnings-28 M-29.4 M
Retained Earnings Total Equity-21.1 M-22.1 M
Earnings Yield(0.01)(0.01)
Price Earnings Ratio(79.07)(83.03)
Price Earnings To Growth Ratio 1.61  1.69 

Currently Active Assets on Macroaxis

When determining whether Sanara Medtech offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Sanara Medtech's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Sanara Medtech Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Sanara Medtech Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sanara Medtech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
For more detail on how to invest in Sanara Stock please use our How to Invest in Sanara Medtech guide.
You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sanara Medtech. If investors know Sanara will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sanara Medtech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.99)
Revenue Per Share
9.241
Quarterly Revenue Growth
0.352
Return On Assets
(0.05)
Return On Equity
(0.20)
The market value of Sanara Medtech is measured differently than its book value, which is the value of Sanara that is recorded on the company's balance sheet. Investors also form their own opinion of Sanara Medtech's value that differs from its market value or its book value, called intrinsic value, which is Sanara Medtech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sanara Medtech's market value can be influenced by many factors that don't directly affect Sanara Medtech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sanara Medtech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sanara Medtech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sanara Medtech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.